China Structural Ventricular Arrhythmias Registry
Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · Jan 27, 2019
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The China Structural Ventricular Arrhythmias Registry is a study looking to better understand a heart condition called ventricular arrhythmia, which can occur due to problems in the heart's structure. Researchers aim to gather information from 2,000 participants across 10 medical centers in China to identify risk factors for severe forms of this condition. If you have been diagnosed with ventricular arrhythmia related to structural heart diseases like ischemic cardiomyopathy or hypertrophic cardiomyopathy, you may be eligible to participate.
If you join the study, your medical history will be reviewed, and blood samples will be taken to help find new indicators that could show your risk level. You'll be followed up with every six months to track any changes in your health. This study is a chance to contribute to better understanding and potentially improving treatment for this serious heart condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.
- Exclusion Criteria:
- • none
About China National Center For Cardiovascular Diseases
The China National Center for Cardiovascular Diseases (NCCD) is a leading research and clinical trial sponsor dedicated to advancing cardiovascular health in China and globally. As a prominent institution, NCCD focuses on innovative research, clinical management, and education in cardiovascular medicine. The center plays a crucial role in conducting rigorous clinical trials aimed at developing new therapies and improving patient outcomes for cardiovascular diseases. Through collaboration with national and international partners, NCCD is committed to enhancing the understanding of cardiovascular conditions and translating research findings into practical applications for improved healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yan Yao, MD,PhD
Study Chair
China National Center for Cardiovascular Diseases
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials